Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9920778 | 0.92 | ALDH1A1 (0.36) | MAPTALDH1A1MAPK1NPSR1RXFP1 | |
| SCHEMBL9920782 | 0.92 | ALDH1A1 (0.34) | MAPTALDH1A1MAPK1NPSR1RXFP1 | |
| SCHEMBL9921090 | 0.92 | ALDH1A1 (0.34) | MAPTALDH1A1MAPK1NPSR1RXFP1 | |
| SCHEMBL9920916 | 0.91 | ALDH1A1 (0.35) | MAPTALDH1A1MAPK1NPSR1FLT3 | |
| SCHEMBL9920775 | 0.90 | FLT3 (0.36) | MAPTALDH1A1MAPK1NPSR1FLT3 | |
| SCHEMBL9920780 | 0.89 | ALDH1A1 (0.34) | MAPTALDH1A1MAPK1NPSR1RXFP1 | |
| SCHEMBL9921108 | 0.89 | ALDH1A1 (0.34) | MAPTALDH1A1MAPK1NPSR1RXFP1 | |
| SCHEMBL9920638 | 0.89 | ALDH1A1 (0.34) | MAPTALDH1A1MAPK1NPSR1RXFP1 | |
| SCHEMBL9920855 | 0.88 | ALDH1A1 (0.34) | MAPTALDH1A1MAPK1NPSR1RXFP1 | |
| SCHEMBL21234890 | 0.88 | NPSR1 (0.35) | MAPTALDH1A1MAPK1NPSR1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463352-B1 | Light emitting device material and light emitting device | TORAY INDUSTRIES (JP) | 2018-05-02 | — | — | EP | disclosed |
| EP-1942171-B1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES (JP) | 2018-04-18 | — | — | EP | disclosed |
| US-20140061629-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2014-03-06 | — | — | US | disclosed |
| US-20140061629-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2014-03-06 | — | — | US | disclosed |
| EP-2463352-A2 | Light emitting device material and light emitting device | Toray Industries, Inc. (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-2463351-A2 | Light emitting device material and light emitting device | Toray Industries, Inc. (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20090096356-A1 | Light-emitting device material and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090096356-A1 | Light-emitting device material and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-1942171-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2008-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090096356-A1 | Light-emitting device material and light-emitting device | PRMT9, CCNL2, MRPL9 | MAPT 3173/4885ALDH1A1 1929/4885MAPK1 1279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.